波士顿科学公司的WATCHMAN FLX装置可降低心脏切除术后心房动患者的出血风险. Boston Scientific’s WATCHMAN FLX device reduces bleeding risk in atrial fibrillation patients post-heart ablation.

波士顿科学公司的 WATCHMAN FLX 装置在心脏消融术后心房颤动患者中，与口服抗凝剂相比，在降低出血风险方面显示出更好的结果。 Boston Scientific's WATCHMAN FLX device showed better outcomes in reducing bleeding risk compared to oral anticoagulants in patients with atrial fibrillation post-cardiac ablation. 涉及1 600名病人的 " 选择试验 " 发现,在预防中风的同时,该装置与口服抗凝胶剂相匹配,同时大幅减少了重大出血事件。 The OPTION trial, involving 1,600 patients, found the device matched oral anticoagulants in stroke prevention while significantly lowering major bleeding incidents. 这使TCHMAN FLX成为长期抗凝胶剂使用可能导致严重出血的病人更安全的替代方案。 This makes WATCHMAN FLX a safer alternative for patients at risk of serious bleeding from long-term anticoagulant use.

November 16, 2024

6 文章